Gyre Therapeutics, Inc.GYRENASDAQ
Loading
EPS Over TimeContracting
Percentile Rank93
3Y CAGR+23.1%
Studio
Year-over-Year Change

Earnings per share

3Y CAGR
+23.1%/yr
Annual compound
Percentile
P93
Near historical high
vs 3Y Ago
1.9x
Solid growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM0.06-59.9%
20240.14+109.9%
2023-1.41-4784.4%
20220.03+101.0%
2021-2.87+2.0%
2020-2.93+33.6%
2019-4.41-64.6%
2018-2.68+57.5%
2017-6.30+71.0%
2016-21.76-